
The legal battle between the PGA Tour and LIV Golf is likely to continue for months and even years, and Tiger Woods is one of the people at the center of the latest chapter.
Larry Klayman, a lawyer representing the lead plaintiff in a case against the PGA Tour, announced in a press release on Thursday that Woods, Rory McIlroy and PGA Tour commissioner Jay Monahan have been subpoenaed over the players-only meeting that was held in Delaware last week. The statement says it is “believed that discussions occurred which are alleged in the above complaint to be anticompetitive and violative of the antitrust laws vis a vis the LIV Golf Tour and its players.”
“This is not a personal ‘thing’ against Woods, McIlroy and Monahan,” Klayman said in the release, via Matt Cradock of Golf Monthly. “It’s about getting information about what occurred at the players’ meeting and generally with regard to allegations in our complaint that the PGA Tour, the DP World Tour and their commissioners Jay Monahan and Keith Pelley, are allegedly colluding in restraint of trade and the antitrust laws to harm the LIV Golf Tour and its players.”
The PGA Tour announced on Wednesday that it will be making sweeping changes for the 2022-23 season. Many of them will give players a chance to earn far more money.
Klayman said those changes are meant “to emulate LIV Golf, while continuing to allegedly harm LIV and its players.”
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Judge Orders Apple to Address Fortnite App Block or Face Court Hearing
May 19, 2025 by
CPI
EU Civil Society Groups and Labor Unions Raise Alarm Over Proposed Changes to GDPR
May 19, 2025 by
CPI
EU Antitrust Regulators Push Back Deadline on UniCredit’s Takeover Bid for Banco BPM
May 19, 2025 by
CPI
Intel Challenges €376 Million EU Fine in Ongoing Antitrust Dispute
May 19, 2025 by
CPI
Red Bull Challenges EU Commission Over Lengthy Antitrust Inspection
May 19, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas